Spotting, also called intermenstrual bleeding, is any light bleeding that happens outside the days of the regular period. It is light enough that a panty liner usually catches it without needing a full pad, the colour is most often pink, light red or brown rather than the deeper red of menstrual flow, and it tends to last a few hours to a day or two rather than the longer arc of a period.

Three small distinctions are useful. Spotting is not a short period; a period that simply runs lighter or shorter than usual is still a period. Spotting is not breakthrough bleeding from contraception, although the two often overlap in early months of a new pill. And spotting is not the same as a discharge tinged pink from cervical mucus around ovulation; a true spot leaves a visible mark on liner or tissue.

Knowing your own baseline matters more than any universal rule. A woman whose cycles are consistently 28 days and who never spots will notice a midcycle pink trace easily. A woman whose cycle is naturally more variable might find that one or two pink days here and there is simply her pattern. Tracking the day of the cycle, the colour, the trigger (after sex, after exercise, mid-cycle) and the duration on an app or a simple diary makes the conversation with a gynec dramatically more productive when one is needed.

• Ovulation spotting — a light pink trace around day 14 of a 28-day cycle, lasting a few hours to a day or two, caused by the brief estrogen dip at ovulation; reassuring when it recurs at the same point each cycle.
• Implantation bleeding — a very light pink or brown spot 8 to 12 days after conception when the fertilised egg burrows into the uterine lining; see implantation bleeding vs early period in India.
• First three months of a new combined oral contraceptive pill — the lining is adjusting to the new hormonal pattern, and light irregular bleeding is so common in this window that it is considered normal unless persistent.
• Missed or late combined pill doses — a missed pill or two in the middle of the pack can trigger a breakthrough bleed that mimics spotting and warns that contraceptive protection has also dropped.
• Recent hormonal IUD (Mirena, Skyla) or copper IUD insertion — irregular spotting in the first three to six months is expected; the hormonal IUD usually settles to very light periods or no periods, while copper IUDs can cause heavier and longer periods overall.
• Emergency contraceptive pill (i-pill, Unwanted-72) — a single high-dose progestin pulse commonly causes light bleeding within a week and can shift the next period by several days.
• Stress, illness, sudden weight change, intense exercise or jet lag — any disruption of the hypothalamic-pituitary-ovarian axis can cause a hormonal blip that shows up as one cycle of spotting.
• Light pink trace once after vigorous sex — usually from cervical ectropion (the inner cervical cells visible on the outside of the cervix) or a fragile small blood vessel, and reassuring if it happens once and does not recur; see bleeding after sex in India.
• Cervical ectropion — a harmless area where the more delicate inner cervical lining is exposed on the outer cervix, especially common in younger women, pill users and pregnancy, often causing painless spotting after sex.
• Perimenopause — in the 40s the ovaries begin to release estrogen and progesterone irregularly, which often shows up as both heavier and lighter cycles and intermittent spotting between them.
• Mild PCOS-pattern cycles — the long anovulatory cycles of PCOS occasionally throw up unpredictable spotting between proper periods; see PCOS isn't your fault.
• Mild thyroid dysfunction — both underactive and overactive thyroid commonly disrupt the cycle and can cause light intermenstrual bleeding.

A smaller list of causes is much less common but matters more because each benefits from prompt diagnosis. Cervical polyps are smooth benign growths from the cervical canal that bleed easily on contact, particularly after sex or a pap smear; they are removed in a quick day-procedure. Endometrial polyps grow from the uterine lining and tend to cause spotting between periods or after the menopause; they are removed at hysteroscopy.

Fibroids, particularly the submucosal type that sits just under the uterine lining, can cause intermenstrual spotting alongside heavier and longer periods. Adenomyosis, where the lining tissue invades the muscle wall, classically causes painful heavy periods but can also produce spotting. Endometriosis can rarely cause cyclical spotting at unusual sites and is more commonly associated with painful periods and infertility.

Infection is an important cause to rule out, especially with foul-smelling discharge, fever or pelvic pain. Sexually transmitted infections, particularly chlamydia and gonorrhoea, cause cervicitis that bleeds on touch and can present with spotting after sex. Pelvic inflammatory disease, the deeper infection that follows untreated STIs, presents with fever, deep pelvic pain and intermenstrual bleeding and is a hospital-level emergency.

Two pregnancy-related causes need same-day attention. An early miscarriage often begins as spotting that progresses to heavier bleeding with cramping. An ectopic pregnancy, where the fertilised egg implants in the fallopian tube, presents with a late or unusual period, spotting and one-sided pelvic pain; it is a surgical emergency. Any woman with a late period and new spotting should take a pregnancy test on the same day.

Cervical and endometrial cancer are the rare but vital causes that drive the medical caution around persistent spotting. Cervical cancer remains the second commonest cause of cancer death in Indian women, often presenting first with painless bleeding after sex or between periods. Endometrial cancer most commonly presents with post-menopausal bleeding but can also cause irregular bleeding in the perimenopausal years. Both are highly treatable when caught early; see cervical cancer screening in India and first-time Pap smear in India.

Several patterns are so consistently benign that a single home tracking-and-wait approach is reasonable as a first step, provided none of the red-flag features below are present. The first is reliable mid-cycle pink spotting that lasts a day or two around day 14 of a 28-day cycle and repeats the same way each month; this is classic ovulation spotting and needs no investigation on its own. The second is the first three months of any new hormonal contraceptive — combined pill, progestin-only pill, hormonal IUD or implant — when the lining is adjusting and light unpredictable bleeding is expected; persistent spotting beyond three to six months on the same method does deserve a review.

The third is a one-off light pink spot once after vigorous sex with no pain, no foul discharge, and no recurrence the next time; this is usually a fragile small vessel or harmless cervical ectropion. The fourth is light spotting once during a particularly stressful, ill or travel-disrupted month that does not recur the next cycle; the hypothalamic-pituitary axis can blip and recover on its own. The fifth, in a woman trying to conceive, is a very light pink or brown spot 8 to 12 days after suspected ovulation that lasts under 48 hours and is followed by a missed period — the picture of implantation bleeding.

Even in these benign-looking situations, a pregnancy test is the right first step for any sexually active woman if there is any possibility of conception. If the pattern repeats reliably over two or three cycles with the features above and no red flags, observation with continued tracking is reasonable. If it changes pattern, gets heavier, starts to hurt or develops any of the red flags in the next section, the right step is a gynec visit.

• Spotting that repeats in three or more consecutive cycles, regardless of how light it is — the cumulative pattern itself is the signal that a polyp, fibroid, hormonal issue or, rarely, a cancer is worth ruling out.
• Spotting after sex on more than one occasion — this needs a speculum exam and Pap smear because cervical ectropion, cervical polyp, infection and cervical cancer are all common explanations.
• Spotting with pelvic pain, fever, foul-smelling discharge or burning urination — these together suggest infection (cervicitis, pelvic inflammatory disease, STI) that needs same-week antibiotics.
• Spotting alongside a late or missed period in any sexually active woman — take a pregnancy test the same day and see a doctor regardless of the result to rule out miscarriage and ectopic pregnancy.
• Heavy spotting that fills a pad in under an hour, or with passage of large clots — this is no longer light bleeding and needs same-day assessment.
• Any vaginal bleeding more than 12 months after the final period (post-menopausal bleeding) — this is the single most important red flag because endometrial cancer needs to be actively ruled out; never assume it is harmless.
• Worsening pattern — spotting that started light and is now becoming heavier, more frequent or longer-lasting from cycle to cycle.
• Personal or family history of cervical, endometrial or ovarian cancer — the threshold for a same-week gynec visit and a Pap smear or ultrasound should be lower.
• New persistent pelvic pain, unexplained weight loss, fatigue or bloating alongside any spotting — these can be early systemic signs that warrant a full work-up.

The diagnostic pathway is built up in steps so the simpler tests come first. A urine or serum beta-HCG pregnancy test is the very first step in any sexually active woman, costing roughly ₹50 for a home strip or ₹300 to ₹1,500 for a lab serum test, because pregnancy-related causes (miscarriage, ectopic) need to be ruled in or out before anything else is considered.

A pelvic examination with a speculum then lets the gynec actually see the cervix and vaginal walls. A visible polyp, a friable cervix that bleeds on touch, a discharge of infection, or an obvious cervical lesion can all be picked up on this five-minute examination. Bimanual examination assesses uterine size, tenderness and any pelvic mass.

Imaging then maps the uterus and ovaries. A transvaginal ultrasound (TVS) costs roughly ₹500 to ₹2,500 in India, gives a much clearer image of the lining and ovaries than a transabdominal scan, and identifies endometrial polyps, submucosal fibroids, ovarian cysts and an unusually thick endometrium that needs further evaluation.

A Pap smear (₹300 to ₹1,500) is added if you are due for one or if there is post-coital bleeding or any visible cervical concern. HPV testing alone or in co-testing with Pap costs ₹1,500 to ₹3,500 and is particularly useful in women aged 30 and over. An STI panel covering chlamydia and gonorrhoea, with high vaginal swab for bacterial vaginosis, candida and trichomonas, is added when infection is suspected.

Hormone tests come in when a hormonal pattern is suspected. TSH for thyroid (₹200 to ₹500) and prolactin (₹400 to ₹1,000) are usually added; FSH, LH, AMH and androgens are added when PCOS or premature ovarian insufficiency is on the differential. A hysteroscopy (₹5,000 to ₹25,000), where a thin camera looks directly inside the uterus, is the gold standard when an intrauterine cause is suspected and can both diagnose and remove polyps in the same sitting. An endometrial biopsy (₹2,000 to ₹8,000) samples the lining and is added when endometrial cancer or hyperplasia needs to be ruled out, particularly in perimenopausal or post-menopausal women.

In India, light bleeding outside the regular period is widely treated as a normal nuisance and rarely brought to medical attention until it has been happening for many months. Several cultural patterns drive this. Menstrual health remains a private topic in many families, the routine gynec visit is not part of the cultural norm for unmarried women, and the cost-and-time burden of taking leave for what feels like a minor symptom is real, especially for women in informal employment. Married women often only seek care when planning a pregnancy or after several months of bleeding worry.

The clinical consequence is that benign and treatable conditions — polyps, fibroids, infection — are picked up later than they need to be, and the small subset of women with cervical or endometrial cancer present at a later stage than is ideal. Cervical cancer is the second commonest cause of cancer death in Indian women, and persistent spotting, particularly painless bleeding after sex, is one of its early and dismissable signs.

Two India-specific opportunities help close this gap. The Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) provides a free gynec examination on the 9th of every month at participating government facilities, which can be a low-friction first contact. Cervical cancer screening (Pap smear and visual inspection with acetic acid) is offered free at many empanelled hospitals under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), and Ayushman Bharat (PM-JAY) covers oncology evaluation and treatment for eligible families.

Telemedicine and online gynec consultations now offer a confidential first conversation for under ₹500, which lowers the cultural barrier for unmarried and younger women and lets the doctor decide whether an in-person speculum exam is needed before any in-clinic visit is booked.

There is no single treatment for spotting because the right treatment depends entirely on what is causing it. Ovulation spotting and the first-three-month settling phase of a new contraceptive usually need nothing more than reassurance and continued tracking; if pill-related spotting persists beyond six months, switching to a different formulation usually resolves it. Stress, weight and travel-related spotting tends to resolve as the underlying trigger eases, sometimes with the help of sleep, regular meals and lighter exercise.

Cervical and endometrial polyps are typically removed in a quick hysteroscopic procedure that costs roughly ₹15,000 to ₹50,000 in private hospitals and is often free at empanelled facilities under Ayushman Bharat; the polyp tissue goes for histology to confirm it is benign. Fibroids causing spotting are managed by their size, position and symptoms: small fibroids often need only observation, medium ones may respond to hormonal medication (progestin pills, hormonal IUD), and larger or symptom-heavy ones may need myomectomy (₹50,000 to ₹2,00,000) or, when family is complete, hysterectomy (₹70,000 to ₹3,00,000).

Infection-related spotting is treated with the appropriate antibiotic or antifungal regimen — a five-to-seven day course for bacterial vaginosis or a single-dose fluconazole for candida, longer regimens for chlamydia, gonorrhoea and pelvic inflammatory disease, and partner treatment for STIs. Cervical ectropion usually needs only observation and reassurance; cautery is offered only if it causes troublesome bleeding. Hormonal causes (PCOS, thyroid, hyperprolactinemia, perimenopause) are managed with the specific treatment for the underlying condition, which then settles the spotting as a downstream benefit. Cancer-related spotting is referred to a gynec-oncologist for staging and a treatment plan combining surgery, radiotherapy and chemotherapy as appropriate.

Post-menopausal bleeding deserves its own section because the rule is simple and absolute. Any vaginal bleeding more than 12 months after the final menstrual period, no matter how light, no matter how brief, is post-menopausal bleeding and is treated as endometrial cancer until investigation proves otherwise. This is not catastrophising — it is the standard of care worldwide. The single most important reason is that endometrial cancer is the commonest gynec cancer in this age group and is highly curable when caught early. Roughly 10 percent of post-menopausal bleeding turns out to be endometrial cancer; the remainder turns out to be benign causes, but the only way to know which is which is to investigate.

The diagnostic pathway is straightforward and well-established. The standard work-up is a transvaginal ultrasound to measure the endometrial thickness (a thickness under 4 mm is reassuring; anything 4 mm or more needs further evaluation), followed by an endometrial biopsy or hysteroscopy with sampling if the lining is thickened or if bleeding persists despite a thin lining. The whole pathway is usually completed within two weeks at a private hospital and is covered free for eligible families at empanelled facilities under Ayushman Bharat.

Two practical points help. First, do not be reassured by a single thin-lining ultrasound if the bleeding continues — recurrent post-menopausal bleeding still needs a biopsy. Second, the very common reflex of attributing post-menopausal bleeding to a urinary tract infection, haemorrhoids, hormone replacement therapy or simply old age, and then waiting, is the single biggest cause of late presentation. The right response to any post-menopausal bleed is a same-week gynec appointment.

• Heavy bleeding that fills a pad in under an hour, with or without large clots — this is no longer spotting and needs same-day assessment for the cause of the bleed and to check the haemoglobin.
• Spotting or bleeding alongside severe pelvic pain, fainting, dizziness, or shoulder-tip pain in any woman of reproductive age — assume ectopic pregnancy until proven otherwise and go to the emergency department for a same-day beta-HCG and ultrasound.
• Pregnancy plus any vaginal bleeding — go to the emergency department or see your obstetrician the same day to rule out miscarriage, ectopic and other pregnancy-related causes; do not wait and observe.
• Foul-smelling vaginal discharge with fever or chills alongside any spotting — pelvic inflammatory disease until proven otherwise; needs same-day antibiotics and assessment.
• Any vaginal bleeding more than 12 months after the final period — always a same-week gynec appointment, never wait-and-see.
• Sudden very heavy bleeding in a woman on anticoagulant medication (warfarin, dabigatran, apixaban) — same-day medical review because the bleeding may be amplified by the medication.

• Myth: any spotting is abnormal and means something is wrong. Fact: spotting is extremely common, much of it is benign, and the goal is to recognise the small subset of patterns that do need investigation rather than to panic at every pink trace.
• Myth: spotting always means pregnancy. Fact: it can be implantation bleeding in a small number of cases, but most spotting in non-pregnant women is hormonal or contraceptive-related; take a pregnancy test if you are sexually active and let the result guide the next step.
• Myth: brown blood is old and dangerous. Fact: brown simply means the blood is older and has had time to oxidise on its way out, often from a previous cycle; brown spotting is in fact often less concerning than fresh bright-red bleeding outside the period.
• Myth: if your period tracker did not predict the spotting, the app is broken. Fact: period-tracking apps reflect only what you log; spotting is unpredictable by definition and the app will become more accurate when you log the day and colour each time.
• Myth: spotting after the menopause is normal because the hormones are fluctuating. Fact: by definition once 12 months have passed without a period the hormones are no longer fluctuating in that way, and any bleeding after this point always needs investigation.